Canada's Access to Medicines Regime background

In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Contexte du Régime canadien d'accès aux médicaments
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2017-03-28 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Régime canadien d'accès aux médicaments", "Organisation mondiale du commerce", "dérogation de dispositions de licence", "Accord de l'OMC", "aspects des droits de propriété intellectuelle qui touchent au commerce", "pays en développement et pays les moins développés", "importer des médicaments et des instruments médicaux"], "en": ["Canada's Access to Medicines Regime", "World Trade Organization", "waive licensing provisions", "WTO Agreement", "Intellectual Property Rights", "developing and least-developed countries", "import high-quality drugs and medical devices"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source